Price Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
CS
Price Capital Management's XBI Position: Q2 2015 in Review
Price Capital Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2015, closing a stake of 44,700 shares — an estimated $3.36M sold.
Price Capital Management first reported a position in XBI in Q1 2015 and held it in 1 quarter. The position peaked at $3.36M in Q1 2015. 193 funds tracked by Wall St. Rank hold XBI as of Q2 2015.
- Price Capital Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2015 after selling out during the quarter.
- Price Capital Management sold 44,700 State Street SPDR S&P Biotech ETF shares in Q2 2015, an estimated $3.36M.
- Price Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2015 and held it in 1 quarter.
- Price Capital Management's State Street SPDR S&P Biotech ETF position peaked at $3.36M in Q1 2015.
- 193 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2015.
Based on Price Capital Management's 13F filing for Q2 2015.